Showing 34,541 - 34,560 results of 86,490 for search '(( 20 ((c decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.15s Refine Results
  1. 34541
  2. 34542
  3. 34543

    Pathogenic species of infection. by Chang Gao (5455919)

    Published 2024
    “…Postoperative wound infection in 74 (29.7%) patients, of whom 51 (20.5%) had infection with multi-drug resistant bacteria. …”
  4. 34544

    Longitudinal Serum Proteomics Characterization of CD19-CAR‑T Cell Therapy for B‑Cell Malignancies by Youming Wang (610986)

    Published 2023
    “…However, treated patients may potentially develop side effects, such as cytokine release syndrome (CRS), the mechanisms of which remain unclear. Here, we collected 43 serum samples from eight patients with B-cell acute lymphoblastic leukemia (B-ALL) before and five time points after CD19-specific CAR-T cell treatment. …”
  5. 34545

    Longitudinal Serum Proteomics Characterization of CD19-CAR‑T Cell Therapy for B‑Cell Malignancies by Youming Wang (610986)

    Published 2023
    “…However, treated patients may potentially develop side effects, such as cytokine release syndrome (CRS), the mechanisms of which remain unclear. Here, we collected 43 serum samples from eight patients with B-cell acute lymphoblastic leukemia (B-ALL) before and five time points after CD19-specific CAR-T cell treatment. …”
  6. 34546

    Longitudinal Serum Proteomics Characterization of CD19-CAR‑T Cell Therapy for B‑Cell Malignancies by Youming Wang (610986)

    Published 2023
    “…However, treated patients may potentially develop side effects, such as cytokine release syndrome (CRS), the mechanisms of which remain unclear. Here, we collected 43 serum samples from eight patients with B-cell acute lymphoblastic leukemia (B-ALL) before and five time points after CD19-specific CAR-T cell treatment. …”
  7. 34547

    Longitudinal Serum Proteomics Characterization of CD19-CAR‑T Cell Therapy for B‑Cell Malignancies by Youming Wang (610986)

    Published 2023
    “…However, treated patients may potentially develop side effects, such as cytokine release syndrome (CRS), the mechanisms of which remain unclear. Here, we collected 43 serum samples from eight patients with B-cell acute lymphoblastic leukemia (B-ALL) before and five time points after CD19-specific CAR-T cell treatment. …”
  8. 34548

    DataSheet5_Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.docx by Qin Wei (1482154)

    Published 2022
    “…<p>Background: G Protein Subunit Gamma 7 (GNG7), an important regulator of cell proliferation and cell apoptosis, has been reported to be downregulated in a variety of tumors including lung adenocarcinoma (LUAD). …”
  9. 34549

    DataSheet2_Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.docx by Qin Wei (1482154)

    Published 2022
    “…<p>Background: G Protein Subunit Gamma 7 (GNG7), an important regulator of cell proliferation and cell apoptosis, has been reported to be downregulated in a variety of tumors including lung adenocarcinoma (LUAD). …”
  10. 34550

    DataSheet3_Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.docx by Qin Wei (1482154)

    Published 2022
    “…<p>Background: G Protein Subunit Gamma 7 (GNG7), an important regulator of cell proliferation and cell apoptosis, has been reported to be downregulated in a variety of tumors including lung adenocarcinoma (LUAD). …”
  11. 34551

    DataSheet1_Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.docx by Qin Wei (1482154)

    Published 2022
    “…<p>Background: G Protein Subunit Gamma 7 (GNG7), an important regulator of cell proliferation and cell apoptosis, has been reported to be downregulated in a variety of tumors including lung adenocarcinoma (LUAD). …”
  12. 34552

    DataSheet4_Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.docx by Qin Wei (1482154)

    Published 2022
    “…<p>Background: G Protein Subunit Gamma 7 (GNG7), an important regulator of cell proliferation and cell apoptosis, has been reported to be downregulated in a variety of tumors including lung adenocarcinoma (LUAD). …”
  13. 34553

    Data Sheet 1_A ROS-responsive, aptamer-targeted graphene oxide nanocomposite for site-specific glutathione release in cerebral ischemia-reperfusion injury.docx by Meiying Li (6051287)

    Published 2025
    “…In a Endothelin-1 (ET-1) induced cortical ischemia model, GO@GSH-FA led to a marked decrease in neurological deficit scores (from 7.20 ± 1.16 to 4.20 ± 0.98) and enhanced neuronal survival relative to untreated animals. …”
  14. 34554

    SB105-A10 treatment inhibits the HIV replication of HIV-1 reference strains and isolates from HIV-1 positive pateints. by Isabella Bon (467395)

    Published 2013
    “…<p>Different concentrations (0, 0.1, 1, 5, 10 and 20 µg/ml) of SB105-A10 were added to HIV-1 reference (<b>A</b>) and isolated (<b>B</b>) strains (100 pg/ml p24) for 1 hours at 37°C and then added to activated PBMCs. …”
  15. 34555
  16. 34556
  17. 34557

    Table1_Impact of systemic hypoxia and blood flow restriction on mechanical, cardiorespiratory, and neuromuscular responses to a multiple-set repeated sprint exercise.docx by Robert Solsona (17876297)

    Published 2024
    “…</p><p>Methods: According to a crossover design, fifteen men completed RSE (three sets of five 10-s sprints with 20 s of recovery) in normoxia (NOR), HYP, and with bilaterally-cuffed BFR at 45% of resting arterial occlusive pressure during sets in NOR. …”
  18. 34558
  19. 34559

    Data_Sheet_1_The effect of montages of transcranial alternating current stimulation on occipital responses—a sham-controlled pilot study.docx by Jingying Wang (4458820)

    Published 2024
    “…</p>Methods<p>In three montage sessions (i.e., Oz-Cz, Oz-cheek, and sham), 10 healthy young adults participated, receiving 20-min 2-mA alpha-tACS. Pattern-reversal visual evoked potentials (VEPs) were measured before tACS (T0), immediately after (T20), and 20 min (T40) after tACS. …”
  20. 34560

    Haematology, Carcass and Fatty Acid Composition of Finishing Broilers Fed Enzyme Supplemented Expeller Copra Meal in Corn-Animal Protein Diets by A Devi (9883892)

    Published 2021
    “…Main effects observed were MUFA and PUFA decrease with the inclusion of ECM in the diet (p<0.05). …”